Bionano: Volatility And Q2 Earnings Under The Spotlight

Bashar Issa
6.28K Followers

Summary

  • Recent volatility mirror renewed meme-trade bonanza, likely to subdue in coming days, instead of a reflection of a change in the company's market position.
  • Several factors distorted the YoY revenue comparison this quarter, contributing to the inflated top-line growth, including the BioDiscovery acquisition.
  • The company suffers from a first-mover disadvantage.

Blood sample for Cytogenetics blood testing to chromosomal analysis of blood for specific gene mutations in certain leukaemias. DNA analysis, chromosomal testing.

Md Babul Hosen/iStock via Getty Images

Investment Thesis

Bionano (NASDAQ:BNGO) shares recovered quickly after an earnings miss that sent its shares down 9% last week following Q2 results that showed widening losses despite rising revenue. Shares continued to advance through the

This article was written by

6.28K Followers
Bashar is a contributing writer at Seeking Alpha, focusing on Long/Short investment ideas, with a geographic focus in North America. Before that, Bashar worked at an Investment Fund in the United Kingdom. He has a Master's degree in Finance from the Queen Mary University of London and a Bachelor's degree in Economics from Middlesex University.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About BNGO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BNGO

Related Stocks

SymbolLast Price% Chg
BNGO
--